Simultaneous point-of-care detection of anemia and sickle cell disease in Tanzania: the RAPID study
- 16 November 2017
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 97 (2) , 239-246
Abstract
Both anemia and sickle cell disease (SCD) are highly prevalent across sub-Saharan Africa, and limited resources exist to diagnose these conditions quickly and accurately. The development of simple, inexpensive, and accurate point-of-care (POC) assays represents an important advance for global hematology, one that could facilitate timely and life-saving medical interventions. In this prospective study, Robust Assays for Point-of-care Identification of Disease (RAPID), we simultaneously evaluated a POC immunoassay (Sickle SCAN™) to diagnose SCD and a first-generation POC color-based assay to detect anemia. Performed at Bugando Medical Center in Mwanza, Tanzania, RAPID tested 752 participants (age 1 day to 20 years) in four busy clinical locations. With minimally trained medical staff, the SCD POC assay diagnosed SCD with 98.1% sensitivity and 91.1% specificity. The hemoglobin POC assay had 83.2% sensitivity and 74.5% specificity for detection of severe anemia (Hb ≤ 7 g/dL). Interobserver agreement was excellent for both POC assays (r = 0.95–0.96). Results for the hemoglobin POC assay have informed the second-generation assay design to be more suitable for low-resource settings. RAPID provides practical feasibility data regarding two novel POC assays for the diagnosis of anemia and SCD in real-world field evaluations and documents the utility and potential impact of these POC assays for sub-Saharan Africa.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (K23 HL128885)
- Cincinnati Children’s Research Foundation (N/A)
This publication has 25 references indexed in Scilit:
- Preliminary Evaluation of a Point-of-Care Testing Device (SickleSCAN™) in Screening for Sickle Cell DiseaseHemoglobin, 2017
- A rapid, inexpensive and disposable point‐of‐care blood test for sickle cell disease using novel, highly specific monoclonal antibodiesBritish Journal of Haematology, 2016
- Characteristics of a rapid, point‐of‐care lateral flow immunoassay for the diagnosis of sickle cell diseaseAmerican Journal of Hematology, 2015
- Prevalence and factors associated with severe anaemia amongst under-five children hospitalized at Bugando Medical Centre, Mwanza, TanzaniaBMC Hematology, 2015
- Validation of a novel point of care testing device for sickle cell diseaseBMC Medicine, 2015
- Evaluation of a Density-Based Rapid Diagnostic Test for Sickle Cell Disease in a Clinical Setting in ZambiaPLOS ONE, 2014
- Sickle Cell Anemia: An Underappreciated and Unaddressed Contributor to Global Childhood MortalityThe Journal of Pediatrics, 2014
- Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimatesThe Lancet, 2013
- Newborn sickle cell disease screening: the Jamaican experience (1995–2006)Journal of Medical Screening, 2007
- Blood transfusion for severe anaemia in children in a Kenyan hospitalThe Lancet, 2002